Ideal candidates for leading with NAD+: Patients over 40 experiencing persistent fatigue that does not resolve with sleep or lifestyle changes Individuals with metabolic syndrome, insulin resistance, or difficulty managing weight despite dietary effort Patients recovering from substance use, where NAD+ IV therapy has shown measurable benefit in reducing withdrawal symptoms and cravings High-performance athletes or executives seeking cognitive edge and faster physical recovery Patients with early neurodegenerative concerns who want evidence-supported mitochondrial support GHK-Cu Dosage and NAD+ Dosage: What Clinical Protocols Actually Use Dosing varies based on delivery route, patient body weight, and clinical goal
BPC-157, derived from a naturally occurring protein, has demonstrated its extraordinary ability to promote tissue healing and regeneration, reduce inflammation, and modulate immune responses
View on PubMed Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model Demonstrated AOD9604 intra-articular injection reduced cartilage degradation and inflammatory markers in a collagenase-induced knee osteoarthritis rabbit model, with the combination of AOD9604 and hyaluronic acid showing additive chondroprotective effects (Ann Clin Lab Sci, 2015)
physicians sometimes recommend alternating sites to minimize local accumulation